Neurotech International Limited (ASX:NTI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0130
0.00 (0.00%)
At close: Mar 27, 2026

Neurotech International Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
4.73000.010.040.21
Other Revenue
2.342.443.181.190.570
7.072.443.181.190.610.21
Revenue Growth (YoY)
8687.82%-23.07%166.00%96.58%194.44%156.86%
Cost of Revenue
-1.47-0.01-0.03-0.02
Gross Profit
8.552.443.171.190.570.23
Selling, General & Admin
3.473.593.512.581.352.31
Research & Development
9.949.945.256.452.585.36
Other Operating Expenses
-0.34-0.35-0.360.020.010
Operating Expenses
12.5313.188.49.053.937.67
Operating Income
-3.99-10.74-5.23-7.85-3.36-7.45
Interest Expense
-----0-0
Interest & Investment Income
0.140.140.160.0600
Other Non Operating Income (Expenses)
-----0.02
EBT Excluding Unusual Items
-3.85-10.6-5.07-7.79-3.36-7.43
Pretax Income
-3.85-10.6-5.07-7.79-3.36-7.43
Net Income
-3.85-10.6-5.07-7.79-3.36-7.43
Net Income to Common
-3.85-10.6-5.07-7.79-3.36-7.43
Shares Outstanding (Basic)
1,0521,036912799697493
Shares Outstanding (Diluted)
1,0521,036912799697493
Shares Change (YoY)
6.75%13.59%14.17%14.56%41.54%218.70%
EPS (Basic)
-0.00-0.01-0.01-0.01-0.00-0.02
EPS (Diluted)
-0.00-0.01-0.01-0.01-0.00-0.02
Free Cash Flow
-2.97-9.02-4.6-6.32-2.96-2.32
Free Cash Flow Per Share
-0.00-0.01-0.01-0.01-0.00-0.01
Gross Margin
120.85%100.00%99.75%100.00%94.40%109.86%
Operating Margin
-56.38%-439.21%-164.52%-657.31%-553.20%-3609.23%
Profit Margin
-54.45%-433.60%-159.54%-652.33%-553.35%-3600.70%
Free Cash Flow Margin
-42.01%-369.18%-144.63%-528.84%-486.88%-1122.53%
EBITDA
-3.99-10.74-5.23-7.85-3.36-
EBITDA Margin
-56.38%--164.50%---
D&A For EBITDA
00000-
EBIT
-3.99-10.74-5.23-7.85-3.36-7.45
EBIT Margin
-56.38%--164.52%---
Advertising Expenses
-000.010.010.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.